CK Life Sciences Int'l., (Holdings) Inc. (HKG:0775)
Hong Kong
· Delayed Price · Currency is HKD 0.720
-0.010 (-1.37%)
Apr 29, 2026, 4:08 PM HKT
HKG:0775 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -186.81 | -126.55 | 17.25 | 131.96 | 162.8 | Upgrade
|
| Depreciation & Amortization | 245.32 | 245.16 | 233.74 | 230.91 | 246.88 | Upgrade
|
| Loss (Gain) From Sale of Assets | -693.46 | -244.83 | -94.63 | -51.51 | 0.76 | Upgrade
|
| Asset Writedown & Restructuring Costs | 401.51 | 136.91 | -39.37 | -43.72 | -61.13 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.66 | -5.4 | 0.35 | -0.52 | 1.05 | Upgrade
|
| Loss (Gain) on Equity Investments | -0.36 | -0.15 | -0.33 | -0.02 | -1.21 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.5 | 5.48 | 0.68 | 20.41 | 2.92 | Upgrade
|
| Other Operating Activities | 416 | 375.35 | 326.92 | 197.27 | 213.09 | Upgrade
|
| Change in Accounts Receivable | -31.88 | -86.9 | 51.43 | -189.54 | -117.36 | Upgrade
|
| Change in Inventory | -126.4 | -50.83 | 54.6 | -95.59 | 16.24 | Upgrade
|
| Change in Accounts Payable | 163.19 | 105.28 | -36.46 | 164.01 | -40.47 | Upgrade
|
| Operating Cash Flow | 186.95 | 353.53 | 514.18 | 363.66 | 423.58 | Upgrade
|
| Operating Cash Flow Growth | -47.12% | -31.24% | 41.39% | -14.14% | -20.22% | Upgrade
|
| Capital Expenditures | -244.98 | -196.53 | -287.68 | -216.02 | -216.2 | Upgrade
|
| Sale of Property, Plant & Equipment | 101.89 | 80.87 | 33.21 | 24.66 | 1.14 | Upgrade
|
| Cash Acquisitions | 62.21 | - | - | - | - | Upgrade
|
| Divestitures | -28.37 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 2.35 | 194.42 | 126.38 | 26.94 | -1.05 | Upgrade
|
| Sale (Purchase) of Real Estate | -53.08 | -60.65 | 46.94 | 179.48 | -44.79 | Upgrade
|
| Investment in Securities | -180.94 | - | - | -42.9 | - | Upgrade
|
| Other Investing Activities | 17.82 | 13.95 | 13.19 | 5.72 | 3.01 | Upgrade
|
| Investing Cash Flow | -346.5 | -96.65 | -67.96 | -22.12 | -257.88 | Upgrade
|
| Long-Term Debt Issued | 2,110 | 1,366 | 3,188 | 1,224 | 1,150 | Upgrade
|
| Long-Term Debt Repaid | -1,654 | -1,372 | -3,268 | -1,480 | -1,176 | Upgrade
|
| Net Debt Issued (Repaid) | 456.46 | -6.5 | -80.17 | -256.23 | -25.87 | Upgrade
|
| Common Dividends Paid | - | - | -76.89 | -96.11 | -96.11 | Upgrade
|
| Other Financing Activities | -263.78 | -335.47 | -320.89 | -163 | -98.1 | Upgrade
|
| Financing Cash Flow | 192.68 | -341.98 | -477.95 | -515.34 | -220.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | 15.97 | -25.26 | 4.12 | -25.07 | -13.81 | Upgrade
|
| Net Cash Flow | 49.1 | -110.35 | -27.61 | -198.87 | -68.2 | Upgrade
|
| Free Cash Flow | -58.03 | 157.01 | 226.51 | 147.64 | 207.37 | Upgrade
|
| Free Cash Flow Growth | - | -30.68% | 53.41% | -28.80% | 6.06% | Upgrade
|
| Free Cash Flow Margin | -1.07% | 2.84% | 4.25% | 2.80% | 3.84% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.02 | 0.02 | 0.01 | 0.02 | Upgrade
|
| Cash Interest Paid | 265.43 | 335.47 | 320.89 | 163 | 98.1 | Upgrade
|
| Cash Income Tax Paid | 98.92 | 17.22 | 66.73 | 48.22 | 18.42 | Upgrade
|
| Levered Free Cash Flow | -199.56 | 87.52 | 57.61 | 90.23 | 109.78 | Upgrade
|
| Unlevered Free Cash Flow | -32.75 | 298.26 | 259.13 | 192.17 | 170.92 | Upgrade
|
| Change in Working Capital | 4.91 | -32.44 | 69.57 | -121.12 | -141.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.